-
1
-
-
84857743319
-
Diagnosing the decline in pharmaceutical R;D efficiency
-
Scannell JW, Blanckley A, Boldon H, et al. Diagnosing the decline in pharmaceutical R;D efficiency. Nat Rev Drug Discov. 2012;11:191-200
-
(2012)
Nat Rev Drug Discov
, vol.11
, pp. 191-200
-
-
Scannell, J.W.1
Blanckley, A.2
Boldon, H.3
-
3
-
-
84952349445
-
The benefits of drug repositioning
-
Spring 11
-
Persidis A. The benefits of drug repositioning. Drug Discovery World. 2012; Spring 11
-
(2012)
Drug Discovery World
-
-
Persidis, A.1
-
5
-
-
5544283545
-
The role of voltage gated T-Type Ca2+channel isoforms in mediating ,capacitative, Ca2 + entry in cancer cells
-
Gray LS, Perez-Reyes E, Gomora JC, et al. The role of voltage gated T-Type Ca2+channel isoforms in mediating ,capacitative, Ca2 + entry in cancer cells. Cell Calcium. 2004;36:489-497
-
(2004)
Cell Calcium
, vol.36
, pp. 489-497
-
-
Gray, L.S.1
Perez-Reyes, E.2
Gomora, J.C.3
-
6
-
-
0033803221
-
Mibefradil block of cloned T-Type calcium channels
-
Martin RL, Lee JH, Cribbs LL, et al. Mibefradil block of cloned T-Type calcium channels. J Pharmacol Exp Ther. 2005;295:302-308
-
(2005)
J Pharmacol Exp Ther
, vol.295
, pp. 302-308
-
-
Martin, R.L.1
Lee, J.H.2
Cribbs, L.L.3
-
7
-
-
84876826531
-
A model for the regulation of T-Type Ca 2 + ) channels in proliferation: Roles in stem cells and cancer
-
Gray LS, Schiff D, Macdonald TL. A model for the regulation of T-Type Ca(2 + ) channels in proliferation: roles in stem cells and cancer. Expert Rev Anticancer Ther. 2013;13:589-595
-
(2013)
Expert Rev Anticancer Ther
, Issue.13
, pp. 589-595
-
-
Gray, L.S.1
Schiff, D.2
MacDonald, T.L.3
-
8
-
-
84876881311
-
Mibefradil, a novel therapy for glioblastoma multiforme: Cell cycle synchronization and interlaced therapy in a murine model
-
Keir ST, Friedman HS, Reardon DA, Bigner DD, Gray LA. Mibefradil, a novel therapy for glioblastoma multiforme: cell cycle synchronization and interlaced therapy in a murine model. J Neurooncol. 2013;111:97-102
-
(2013)
J Neurooncol
, vol.111
, pp. 97-102
-
-
Keir, S.T.1
Friedman, H.S.2
Reardon, D.A.3
Bigner, D.D.4
Gray, L.A.5
-
10
-
-
84952349447
-
Mibefradil increases paclitaxel,s effect on MCF-7 cell proliferation in vitro and in vivo (abst)
-
Abstract 5672
-
Pottle J, Sun C, Gray L, Li M. Mibefradil increases paclitaxel,s effect on MCF-7 cell proliferation in vitro and in vivo (abst). Cancer Res. 2012;72 Suppl 1: Abstract 5672
-
(2012)
Cancer Res
, vol.72
, Issue.SUPPL1
-
-
Pottle, J.1
Sun, C.2
Gray, L.3
Li, M.4
-
11
-
-
84952306717
-
Mibefradil enhances the tumoricidal effect of radiation therapy in an intracranial glioma model (abst
-
Xu Z, Popp B, Schlesinger D, et al. Mibefradil enhances the tumoricidal effect of radiation therapy in an intracranial glioma model (abst). Neuro-Oncology. 2012;14:25
-
(2012)
Neuro-Oncology
, vol.14
, pp. 25
-
-
Xu, Z.1
Popp, B.2
Schlesinger, D.3
-
12
-
-
84952312011
-
Targeting T-Type calcium channels induces the extrinsic apoptotic pathway and sensitizes glioblastoma cancer cells to radio- and chemotherapy (abst
-
Dziegielewski J, Valerie NCK, Dziegielewska B, et al. Targeting T-Type calcium channels induces the extrinsic apoptotic pathway and sensitizes glioblastoma cancer cells to radio- and chemotherapy (abst). Cancer Res. 2012;72:272
-
(2012)
Cancer Res
, vol.72
, pp. 272
-
-
Dziegielewski, J.1
Nck, V.2
Dziegielewska, B.3
-
13
-
-
84952349448
-
Sequential therapy with the selective T-Type calcium channel blocker mibefradil and temozolomide in patients with recurrent high-grade gliomas: An Adult Brain Tumor Consortium phase i study (ABTC1101
-
TPS2105
-
Holdhoff M, Grossman SA, Supko J, et al. Sequential therapy with the selective T-Type calcium channel blocker mibefradil and temozolomide in patients with recurrent high-grade gliomas: an Adult Brain Tumor Consortium phase I study (ABTC1101). J Clin Oncol. 2013;31:TPS2105
-
(2013)
J Clin Oncol
, vol.31
-
-
Holdhoff, M.1
Grossman, S.A.2
Supko, J.3
|